Accuri Cytometers

About:

Accuri Cytometers is a medical device company developing cost effective cytometers for laboratories.

Website: http://www.accuricytometers.com

Top Investors: F-Prime Capital, Fidelity, Western Technology Investment, Eight Roads Ventures, Arboretum Ventures

Description:

Accuri Cytometers was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument. As a result, the company is looking to develop affordable and robust cytometers.

Total Funding Amount:

$32.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)uni-chem.rs

Founders:

Collin Rich, Jennifer Baird

Number of Employees:

51-100

Last Funding Date:

2010-10-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai